Side by side
Argireline vs SNAP-8
Both are discussed for skin & hair. What this site records about each, side by side. Every figure is on the compound's own page with the source it came from.
| Argireline | SNAP-8 | |
|---|---|---|
| What it is | A topical peptide marketed as a needle-free alternative to botulinum toxin. It has real published studies, small effects, and essentially no risk. | An extended version of Argireline, sold on the same needle-free-Botox premise. Longer peptide, same penetration problem, and less independent evidence. |
| EvidenceHow much human evidence exists, not how well it works. | Early human trials | Early human trials |
| Regulatory statusReviewed 2026-08-16 | Sold as a cosmetic ingredient, not a drug, in the United States, the European Union and elsewhere. Cosmetics are not assessed for efficacy before sale, and claims must stay within cosmetic language. That is why products describe the appearance of wrinkles instead of treating them. | Sold as a cosmetic ingredient, not a drug, in the United States, the European Union and elsewhere. Cosmetics are not assessed for efficacy before sale, and claims must stay within cosmetic language. That is why products describe the appearance of wrinkles instead of treating them. |
| Routes | Topical | Topical |
| Cheapest per mgVials only, read from vendors' own listings and dated on the price index. | $0.49/mg | $0.49/mg |
| Median per mg | $1.09/mg | $3.00/mg |
| Vendors with a price | 4 | 21 |
| Storage once mixed | A finished cosmetic contains a preservative system and typically lasts 6 to 12 months after opening. A serum mixed at home from raw powder does not have that protection and will grow bacteria. That is the practical risk with this compound, and it is microbiological rather than pharmacological. | A finished cosmetic has a preservative system and typically lasts 6 to 12 months after opening. A home mix has none and will grow bacteria within weeks, near your eyes. |
Compare two other compounds · The full price index
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on BioAlmanac is medical advice. Nothing here ranks these two against each other. A table can show that one has more human evidence behind it or costs less per milligram; neither of those is a recommendation, and the right comparison for any person is one their doctor makes with them.